Cleardebt to de-list from AIM as profits sink on reduced margins

Shares in Cleardebt Group lost over 60 per cent of their value on Thursday after announcing plans to cancel its admission on AIM on the back of a disappointing set of half year results.

Shares in Cleardebt Group lost over 60 per cent of their value on Thursday after announcing plans to cancel its admission on AIM on the back of a disappointing set of half year results.

Hit by a reducation in individual voluntary arrangements (IVAs), pre-tax profit for the second half of 2012 fell 73% from £0.45m to £0.12m, on revenues of £4.66m, which were up two per cent compared to £4.55m the prior year.

Gross margins for the period were reduced substantially to 41% (2011: 53%), reflecting increased marketing costs and high sales focused payroll costs spread over poor levels of new business in the period.

New IVAs in the period declined to 689 (2011: 833), largely due to the fact that referrals from OFT-compliant lead sources are proving harder to come by as many are increasingly restricted to fewer legitimate data sources, driving prices up in some cases but mainly reducing the volumes of referrals. The group said it is continuing to expand its compliant referral base and look for new referral sources.

More positively, cash at the period end stood at £1.41m, compared to £0.46m at June 30th.

Chief Executive Officer David Mond said: "This was a disappointing and difficult half-year borne out by a continuation of the general trend of falling personal insolvency numbers in the UK over recent quarters. We have felt the effect of this with poor volumes of new IVAs passed in the period although we have increased the numbers of clients under debt management.

"We are however expecting increased fee income derived from mis-sold payment protection insurance claims as claims for our clients in an IVA are submitted and proceeds are received into the IVAs. ClearCash is making progress on its new platform with its enhanced product offering proving more attractive to consumers."

The group also said that it can no longer justify the costs associated with its AIM listing.

"We have been unable to obtain funding from the AIM markets for some time now and we see no prospect of doing so in the near future due to our low market capitalisation and our business sector and continue to rely on funding from our main shareholder in order to make acquisitions and finance the business," it said.

"We intend to put in place a matched bargain facility for shareholders who wish to buy or sell the Group's shares once we have delisted."

The share price fell 62.50% to 0.30p by 13:37.

NR

Recommended

The top funds to invest in
Funds

The top funds to invest in

As market volatility and recessionary fears continue, here are the most popular funds, stocks and trusts investors are putting their money into accord…
2 Feb 2023
The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves takes a look at the companies with the highest dividend yields in the UK’s blue-chip index
23 Jan 2023
The top ten dividend stocks in the FTSE 250
Share tips

The top ten dividend stocks in the FTSE 250

The average FTSE 250 dividend yield is around 4%, but many stocks yield much more. Rupert Hargreaves picks the best FTSE 250 stocks for income investo…
17 Jan 2023
Investing trends to watch out for in 2023: what analysts say
Investment strategy

Investing trends to watch out for in 2023: what analysts say

What are sensible strategies for high inflationary times? We ask analysts to find out.
22 Dec 2022

Most Popular

When will interest rates go up?
UK Economy

When will interest rates go up?

Interest rates are now at 4%, and they could rise further in the months ahead.
3 Feb 2023
NS&I brings back one-year fixed bonds with highest rates since 2010
Personal finance

NS&I brings back one-year fixed bonds with highest rates since 2010

NS&I’s one-year fixed bonds are back on sale after being pulled off the market in 2019 - but is the rate any good?
1 Feb 2023
Covid-19 vaccines helped these stocks take off, but what’s next for these companies?
Investments

Covid-19 vaccines helped these stocks take off, but what’s next for these companies?

Dominic Frisby explores how the top vaccine stocks are doing as booster take-up remains at a low
2 Feb 2023